Flu

Americans wondering if they have COVID-19 or the flu will soon be able to take one at-home test to figure it out. On Monday, the Food and Drug Administration approved the first at-home test that can detect COVID-19, influenza A and B and another common virus, RSV, or respiratory syncytial virus.

Respiratory syncytial virus (RSV), just authorized by the FDA, will be available without a prescription. "In early June, the kit will initially be available online via Labcorp OnDemand," says Jacob Rund, a spokesperson for the test maker, Labcorp. Users can collect their own nasal sample at home and send it...

With the number of new COVID-19 variants and wild strains evolving, Americans are reporting an increasing number of reinfections of the virus across the country.According to the Centers for Disease Control and Prevention (CDC), reinfection with the virus that causes COVID-19 means a person was infe…

The new normal is now. In what seemed like an instant, COVID-19 became an inevitable aspect of everyday life more than two years ago — with no signs to suggest that we’ll ever see otherwise again. As we look at our lives ahead with waves of new variants and “stealth” sub-variants, and seasonal vaccine boosters to match, it begs the question: Should we fear reinfection? Doctors have recently confirmed that those infected with an earlier Omicron variant, which first appeared and spread rapidly last summer, can indeed test positive again for the new sub-variant. Last week, as the latest strain — BA.2 or BA2.12.1...

The U.S. Food and Drug Administration issued its approval Monday of the first non-prescription at-home COVID-19 test that also detects the flu. The test allows users to swab the inside of their nose and send the sample to the test’s manufacturer, Labcorp, for analysis. In addition to influenza A and B and COVID-19, the test can also detect respiratory syncytial virus, more commonly called RSV.

Data on hospitalizations of children during the pandemic highlighted the seriousness of MIS-C, particularly in children of color. COVID-19 infection in children, and the rare but potentially devastating outcome known as multisystem inflammatory syndrome in children (MIS-C), have made headlines for the past 2 years. While scientists’ knowledge about these conditions has grown by leaps and bounds, until recently there was a dearth of information about the severity of these illnesses in the pediatric population compared with influenza and respiratory syncytial virus (RSV), the most common viruses acquired in childhood.

The Food and Drug Administration authorized the first non-prescription COVID-19 test that can also detect the flu and RSV, the agency announced on Monday. Driving the news: In addition to COVID-19, the test can detect other respiratory viruses, including influenza A and B, commonly known as the flu, and respiratory syncytial virus, also known as RSV.

A virus is made up of genetic material that requires a living host to survive. It invades the cells of that host and essentially "rewrites" the instructions for the way the cell operates. While the virus is occupying the host, it works hard to replicate (make copies of itself) so that it can survive until moving on to the next. As viruses move from person to person in search of survival, they can mutate—or change—over time.

The COVID-19 pandemic is still ongoing over two years after it started. In the U.S., deaths from the disease have been relatively high in other similar countries. About one in 330 Americans have died from COVID-19. One million Americans have died since the start of the pandemic, according to the.

More than 11 billion COVID-19 vaccines have been given and the focus is shifting to children in many countries. The World Health Organization’s chief scientist explains how safe COVID-19 vaccines are for children. The roll-out of COVID-19 vaccinations has raised hopes that vaccines against other germs will be fast-tracked...

Canberra, May 18 (SocialNews.XYZ) The Australian Medical Association (AMA) on Wednesday called for a return of face masks to mitigate an impending spike in Covid-19 and influenza cases.

This is the first test authorized for all 3 viruses and is over the counter. The Food and Drug Administration (FDA) granted an Emergency Use Authorization (EUA) to the Labcorp Seasonal Respiratory Virus RT-PCR DTC Test for use without a prescription for people with symptoms of respiratory viral infection consistent with COVID-19. This product is the first direct-to-consumer multi-analyte COVID-19 test authorized by FDA.